These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14553886)

  • 21. Images in clinical medicine. Serpentine supravenous hyperpigmentation.
    Chan CC; Lin SJ
    N Engl J Med; 2010 Jul; 363(5):e8. PubMed ID: 20830826
    [No Abstract]   [Full Text] [Related]  

  • 22. Metallic taste as a side effect of topical fluorouracil use.
    Han SY; Youker S
    J Drugs Dermatol; 2011 Oct; 10(10):1201-3. PubMed ID: 21968673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous recall reactions with systemic fluorouracil.
    Kirkup ME; Narayan S; Kennedy CT
    Dermatology; 2003; 206(2):175-6. PubMed ID: 12592090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe systemic effects with topical fluorouracil.
    Prescrire Int; 2001 Dec; 10(56):184. PubMed ID: 11824445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of various dosage of ketoprofen salt suppositories in acute inflammatory disease in infants (3-36 month old) and children (3-13 year old)].
    Carnelli VE; Mei VA; Cera R; Clemente E; Previtali M
    Minerva Pediatr; 1995 May; 47(5):199-205. PubMed ID: 7643821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversible findings of restricted diffusion in 5-fluorouracil neurotoxicity.
    Lucato LT; McKinney AM; Short J; Teksam M; Truwit CL
    Australas Radiol; 2006 Aug; 50(4):364-8. PubMed ID: 16884425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-steroidal anti-inflammatory drug for pulmonary administration: design and investigation of ketoprofen lysinate fine dry powders.
    Stigliani M; Aquino RP; Del Gaudio P; Mencherini T; Sansone F; Russo P
    Int J Pharm; 2013 May; 448(1):198-204. PubMed ID: 23528281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Fluorouracil-induced severe but reversible cardiogenic shock: a case report.
    Akhtar SS; Wani BA; Bano ZA; Salim KP; Handoo FA
    Tumori; 1996; 82(5):505-7. PubMed ID: 9063536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The efficacy of and tolerance for ketoprofen lysine salt in solution for oropharyngeal use in inflammatory lesions of the oral cavity].
    Natale F; de' Lorenzi C
    Minerva Stomatol; 1997 May; 46(5):273-8. PubMed ID: 9265098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy.
    Yeh KH; Cheng AL
    Br J Cancer; 1997; 75(3):464-5. PubMed ID: 9020500
    [No Abstract]   [Full Text] [Related]  

  • 31. Symptomatic 5-fluorouracil-induced sinus bradycardia.
    Lee AD; McKay MJ
    Intern Med J; 2011 Jul; 41(7):566-70. PubMed ID: 21762335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Patient preference for oral chemotherapy].
    Schöffski P
    Krankenpfl J; 2002; 40(1-2):40-1. PubMed ID: 12035416
    [No Abstract]   [Full Text] [Related]  

  • 33. [Efficacy and tolerability 80 mg granulated ketoprofen lysine salt in posttraumatic orodental pain: double blind vs placebo study].
    Balzanelli B; de Lorenzi C
    Minerva Stomatol; 1996; 45(1-2):53-9. PubMed ID: 8741094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin.
    Aki Z; Kotiloğlu G; Ozyilkan O
    Am J Gastroenterol; 2000 Apr; 95(4):1093-4. PubMed ID: 10763974
    [No Abstract]   [Full Text] [Related]  

  • 35. Two cases of coronary vasospasm induced by 5-fluorouracil.
    Atar A; Korkmaz ME; Ozin B
    Anadolu Kardiyol Derg; 2010 Oct; 10(5):461-2. PubMed ID: 20929706
    [No Abstract]   [Full Text] [Related]  

  • 36. Cicatricial Ectropion With Topical 5% Fluorouracil Cream.
    Tsui M; Tajirian A
    Dermatol Surg; 2016 Aug; 42(8):1005-6. PubMed ID: 27191780
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of the NSAID ketoprofen lysine salt in glucose-6-phosphate dehydrogenase (G6PD) deficiency in inflammatory disease in children].
    Corda R; Carnelli V
    Pediatr Med Chir; 1996; 18(4):391-4. PubMed ID: 9064672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis.
    Jorizzo J; Stewart D; Bucko A; Davis SA; Espy P; Hino P; Rodriguez D; Savin R; Stough D; Furst K; Connolly M; Levy S
    Cutis; 2002 Dec; 70(6):335-9. PubMed ID: 12502122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Capsule instead of infusion--new oral chemotherapy option].
    Köhne CH
    Krankenpfl J; 2002; 40(1-2):42-3. PubMed ID: 12035417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.